Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Baltimore, Maryland, 21201, United States
NCT Number: NCT06312579
Foot ulcers and amputations are a common and feared complication for people with diabetes. People with a diabetic foot ulcer have a higher risk of dying within five years than people with diabetes without an ulcer. At least one in four people with a new diabetic foot ulcer will die within five years, largely due to cardiovascular causes. The reasons for this increased mortality involve decreased mobility.
People with a recently healed diabetic foot ulcer are considered "in remission" as opposed to "cured" because the underlying medical problems which led to their ulcer are still present. Once in remission, the current standard of care is to slowly increase ambulation. The problem is that people rarely return to the recommended level of mobility. The ability to safely maintain mobility with aging is critical.
This pilot study is a small clinical trial to test the feasibility and acceptability of a home-based exercise regimen. The investigators will also assess if this home-based exercise regimen can increase mobility and function without increasing diabetic foot ulcer recurrence by improving lower extremity strength, lower extremity tissue perfusion and glycemic control.
This study is active but is not currently recruiting participants.
50 year and older
All sexes
Interventional
Not applicable
Baltimore, Maryland, 21201, United States
Population: 25 Veterans with a healed foot ulcer in the last 3-15 months
Site: VA Maryland Health Care System (VAMHCS)
Study Duration: Approximately 2 years
Study Design: Randomized, outcome assessor blinded, clinical trial comparing a) a 12-week home-based exercise regimen to b) standard of care
Objectives:
Primary: To assess the feasibility and acceptability of the intervention.
Secondary:
Treatment Regimens: 12-week home-based exercise regimen to standard of care
Duration of Participant's Participation: Up to 31 weeks
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Consistent with current physical activity recommendations for older adults, participants randomized in this arm will be prescribed 5 days/week of exercise, with seated cycling exercise performed on 3 days a week (Monday, Wednesday and Friday), and strength/balance exercise performed 2 days a week (Tuesday and Thursday).
Participants in this group will be provided with guidance on the current standard of care. This includes guidance that these patients should slowly increase ambulation with appropriately fitted footwear.
Time frame: 12-weeks
Usual gait speed will be calculated based on a 10-meter walk distance. The investigators will provide individuals with a 14-meter path for walking to provide room for a "flying start." The participant will walk 14 meters, but gait speed will only be timed during the intermediate 10 meters. This will allow us to determine gait speed without the confounding factor of acceleration and deceleration.
Time frame: 12-weeks
Acceptable recruitment will be assessed among those in the intervention. Acceptable recruitment is defined as 90% of targeted enrollment within 15 months of initiating recruitment efforts.
Time frame: 12-weeks
Physical activity will be assessed as average steps per day, measured with a FitBit.
Time frame: 12-weeks
Acceptability will be measured using the Usage Rating Profile-Intervention (URPI). A higher score indicates greater acceptability of the intervention. The URPI uses a 6-point Likert scale from 1 (strongly disagree) to 6 (strongly agree)
Time frame: 12-weeks
Knee extension and plantar flexion strength will be assessed using a MicroFET 2 Hand-held Dynamometer
Time frame: 12-weeks
Cutaneous perfusion will be assessed on the dorsal and plantar surfaces of the foot using laser Doppler flowmetry using the PeriFlux System 5000
Time frame: 12-weeks
Blood samples will be obtained by venipuncture of a vein in the upper extremity for HbA1c measurement.
Time frame: 12-weeks
Community mobility will be assessed using the Life-Space Assessment (LSA).
Time frame: 12-weeks
Acceptability will be measured through a semi-structured interview.
Time frame: 12-weeks
Adherence to the exercise regimen will be assessed using written logs of home-based exercise, attendance to virtual group exercise, and anonymized FitBit accounts.
Time frame: 12-weeks
Retention will be assessed among those in the intervention. Acceptable retention will be assessed by 80% participation in exercise intervention and study visits.
Time frame: 12-weeks
Community mobility will be assessed using the Life-Space Assessment (LSA).
VA Office of Research and Development
Fed
Home-based Exercise to Improve Functional Outcomes in Veterans With Recently Healed Diabetic Foot Ulcer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07674420
Cardiovascular Diseases, Diabetes
Baltimore, Maryland, United States
View Trial DetailsNCT06531512
Cardiovascular Diseases, Diabetes Complications
Jiangmen, Guangdong, China
View Trial DetailsNCT06402565
Cardiovascular Diseases, Diabetes Complications
Phoenix, Arizona, United States
View Trial DetailsNCT06565156
Cardiovascular Diseases, Diabetes Complications
Guntersville, Alabama, United States
View Trial Details